Europe Non-Invasive Fat Reduction Market

Europe Non-Invasive Fat Reduction Market Size

The non-invasive fat reduction market size in Europe was valued at USD 0.57 billion in 2025. The European market is estimated to be worth USD 1.80 billion by 2034 from USD 0.65 billion in 2026, growing at a CAGR of 13.62% from 2026 to 2034.

MARKET DRIVERS

Increase in Obesity and Rising Demand for Non-Invasive Fat Reduction

The growth of the European non-invasive fat reduction market is experiencing an alarming rise in obesity due to the consumption of fast foods and high-calorie beverages, and a sedentary lifestyle. Excess body fat has a detrimental effect on health with several health complications such as hyperlipidemia, fatty liver, diabetes, etc. Hence, people are turning to fat reduction and body reshaping through non-invasive procedures and cosmetic procedures, which has fueled the market's growth.

According to WHO, more than 1.95 billion adults (aged 18 and older) were overweight, and more than 655 million were obese children under five years old, with an estimated 41 million overweight children in 2017. Around 2.5 million deaths each year are attributable to obesity and its complications. A recent OECD project indicated a steady increase in the obesity rate until 2030. England is studied to represent 39% of the obese population by 2030.

The constant evolution for product innovations due to high demand for technologically superior products which are easy to use and produce faster results is also positively impacting the studied market. For instance, ultrasonic fat removal or liposuction liquefies fat cells by ultrasound waves.

According to the British Association of Aesthetic Plastic Surgeons, we performed over 2,500 liposuction procedures in the UK in 2018. Therefore, due to the large number of procedures performed each year, coupled with the added benefits of fat reduction, the Europe non-invasive fat reduction market is studied to register a high growth rate in the future.

MARKET RESTRAINTS

High Cost of Obesity Medication Development and Market Competition

The high cost of developing obesity medications poses dangers and limits that could hamper the market's growth. Moreover, alternative procedures and stiff market competition will challenge the market growth rate.

REGIONAL ANALYSIS

Geographically, the United Kingdom Non-Invasive Fat Reduction Market dominated the market and will follow this same trend during the forecast period. Various factors, such as a constant supply of new products from well-established and upcoming manufacturers, a variety of fat reduction procedures such as gastric bypass, adjustable gastric banding, gastric sleeve surgery, and intragastric balloon therap,y will create new opportunities for this market.

In 2019/19, there were 876,000 hospital admissions in which obesity was a factor, a 23% increase from the previous period. Furthermore, a 4% increase in hospital admissions was directly attributable to obesity, with a whopping 11,117 in total. The report on Obesity, Physical Activity, and Diet, England in 2020, also found that most adults were overweight or obese, with nearly 67% for men and 60% for women, while 20% of 6-year-olds were classified as obese. Therefore, with the high incidence of obesity in the U.K., the demand for non-invasive fat reduction is expected to increase soon.

The German Non-Invasive Fat Reduction Market will grow at a high CAGR during the analysis period. The presence of established manufacturers, introducing advanced products regularly, coupled with the increased purchasing power of the people, is driving this market.

KEY MARKET PLAYERS

Promising Companies leading the Europe Non-Invasive Fat Reduction Market Profiled in the Report are Fosun Pharmaceutical Co., Ltd., Cutera, Inc., BTL Industries, Invasix Aesthetic Solutions, Cynosure, Inc., ZELTIQ Aesthetics, Inc., Solta Medical, Syneron Medical Ltd., and Venus Concept.

MARKET SEGMENTATION

This Europe non-invasive fat reduction market research report is segmented and sub-segmented into the following categories.

By Technology

• Cryolipolysis
• Low-Level Lasers
• Ultrasound.

By End User

• Cosmetic Centers
• Dermatology Clinics
• Hospitals

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe